TOP N44
Alternative Names: TOP-N-44Latest Information Update: 15 Sep 2021
At a glance
- Originator Topadur Pharma
- Class Anti-inflammatories; Antifibrotics; Skin disorder therapies
- Mechanism of Action Immunosuppressants; Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Burns; Scars
Most Recent Events
- 01 Aug 2021 Preclinical trials in Burns in Switzerland (Topical) before August 2021 (Topadur Pharma pipeline, August 2021)
- 01 Aug 2021 Preclinical trials in Scars (Prevention) in Switzerland (Topical) before August 2021 (Topadur Pharma pipeline, August 2021)